Erasca shares cut in half after patient death in clinical trial
Go back to Erasca shares cut in half after patient death in clinical trial| (NASDAQ: ERAS) | Delayed: 19.51 +0.13 (0.67%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $19.38 | 52 Week High | $ | |||
| Open | $18.94 | 52 Week Low | $ | |||
| Day High | $19.81 | P/E | N/A | |||
| Day Low | $18.86 | EPS | $ | |||
| Volume | 3,076,576 | |||||
